Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition - Narrative (Details)

v3.22.2.2
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Revenue Recognition      
Proceeds from non-Medicare laboratory services $ 0.7    
Proceeds from Laboratory Services Reimbursed by Medicare   $ 0.5  
Contract with Customer, Liability, Total 24.0   $ 25.5
Contract with Customer, Liability, Revenue Recognized $ 10.6